Structural insight into the molecular mechanism of p53-mediated mitochondrial apoptosis
The DOI matches its Crossref record; 9 of the 9 references it cites were found in a registry or an index.
Abstract
The tumor suppressor p53 is mutated in approximately half of all human cancers. p53 can induce apoptosis through mitochondrial membrane permeabilization by interacting with and antagonizing the anti-apoptotic proteins BCL-xL and BCL-2. However, the mechanisms by which p53 induces mitochondrial apoptosis remain elusive. Here, we report a 2.5 Å crystal structure of human p53/BCL-xL complex. In this structure, two p53 molecules interact as a homodimer, and bind one BCL-xL molecule to form a ternary complex with a 2:1 stoichiometry. Mutations at the p53 dimer interface or p53/BCL-xL interface disrupt p53/BCL-xL interaction and p53-mediated apoptosis. Overall, our current findings of the bona fide structure of p53/BCL-xL complex reveal the molecular basis of the interaction between p53 and BCL-xL, and provide insight into p53-mediated mitochondrial apoptosis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The domain following the PRD is the DBD (AA residues 95–292), which is the core domain of p53. The basic scaffold of the DBD contains an immunoglobulin-like β-sandwich and two large loops (L2 and L3).27”
From p53: from understanding its structure to advances in therapeutic targeting (2026) · cites this paper as [27]
In the citing paper
“p53 also binds to several antiapoptotic proteins, including Bcl-2, Mcl-1, and Bcl-xL, indirectly inducing apoptosis.27”
From p53: from understanding its structure to advances in therapeutic targeting (2026) · cites this paper as [27]
In the citing paper
“p53 binds physically to anti-apoptotic proteins (Bcl-2, Bcl-xL and Mcl-1), thereby indirectly inducing apoptosis.71”
From Targeting p53 pathways: mechanisms, structures, and advances in therapy (2023) · cites this paper as [71]
In the citing paper
“However, the recently determined crystal structure of the p53/BCL-xL complex indicates that p53 binds BCL-xL with a 2:1 stoichiometry71 (Fig. 7g).”
From Targeting p53 pathways: mechanisms, structures, and advances in therapy (2023) · cites this paper as [71]
In the citing paper
“The resulting p53-DBD dimer forms a groove and interacts with one BCL-xL to form a ternary complex.”
From Targeting p53 pathways: mechanisms, structures, and advances in therapy (2023) · cites this paper as [71]
2 more claims about this paper
Create a free account to see every claim other papers make about this one.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
HADDOCK: A Protein−Protein Docking Approach Based on Biochemical or Biophysical Information
Dominguez, C., Boelens, R., & Bonvin, A. M. J. J. (2003) · Journal of the American Chemical Society · doi:10.1021/ja026939x · Cited by 3,187
Crystal Structure of a p53 Tumor Suppressor-DNA Complex: Understanding Tumorigenic Mutations
Cho, Y., Gorina, S., Jeffrey, P. D., & Pavletich, N. P. (1994) · Science · doi:10.1126/science.8023157 · Cited by 2,551
Regulation of apoptosis in health and disease: the balancing act of BCL-2 family proteins
Singh, R., Letai, A., & Sarosiek, K. (2019) · Nature Reviews Molecular Cell Biology · doi:10.1038/s41580-018-0089-8 · Cited by 2,111
Direct Activation of Bax by p53 Mediates Mitochondrial Membrane Permeabilization and Apoptosis
Chipuk, J. E., Kuwana, T., Bouchier-Hayes, L., Droin, N. M., Newmeyer, D. D., Schuler, M., & Green, D. R. (2004) · Science · doi:10.1126/science.1092734 · Cited by 2,108
Kastenhuber, E. R., & Lowe, S. W. (2017) · Cell · doi:10.1016/j.cell.2017.08.028 · Cited by 1,906
Fridman, J. S., & Lowe, S. W. (2003) · Oncogene · doi:10.1038/sj.onc.1207116 · Cited by 1,401
The multiple mechanisms that regulate p53 activity and cell fate
Hafner, A., Bulyk, M. L., Jambhekar, A., & Lahav, G. (2019) · Nature Reviews Molecular Cell Biology · doi:10.1038/s41580-019-0110-x · Cited by 1,129
Cytoplasmic functions of the tumour suppressor p53
Green, D. R., & Kroemer, G. (2009) · Nature · doi:10.1038/nature07986 · Cited by 1,106
Rivlin, N., Brosh, R., Oren, M., & Rotter, V. (2011) · Genes & Cancer · doi:10.1177/1947601911408889 · Cited by 1,033
Research works printed but not linked: 38
- Levine, A. J. p53: 800 million years of evolution and 40 years of discovery. Nat. Rev. Cancer 20, 471–480 (2020). · DOI · Paper page
- Joerger, A. C. & Fersht, A. R. The p53 pathway: origins, inactivation in cancer, and emerging therapeutic approaches. Annu. Rev. Biochem. 85, 375–404 (2016). · DOI · Paper page
- Chen, Y., Dey, R. & Chen, L. Crystal structure of the p53 core domain bound to a full consensus site as a self-assembled tetramer. Structure 18, 246–256 (2010). · DOI · Paper page
- Chen, Y. et al. Structure of p53 binding to the BAX response element reveals DNA unwinding and compression to accommodate base-pair insertion. Nucleic Acids Res. 41, 8368–8376 (2013). · DOI · Paper page
- Kitayner, M. et al. Diversity in DNA recognition by p53 revealed by crystal structures with Hoogsteen base pairs. Nat. Struct. Mol. Biol. 17, 423–429 (2010). · DOI · Paper page
- Leu, J. I., Dumont, P., Hafey, M., Murphy, M. E. & George, D. L. Mitochondrial p53 activates Bak and causes disruption of a Bak-Mcl1 complex. Nat. Cell Biol. 6, 443–450 (2004). · DOI · Paper page
- Mihara, M. et al. p53 has a direct apoptogenic role at the mitochondria. Mol. Cell 11, 577–590 (2003). · DOI · Paper page
- Li, M., Wang, D., He, J., Chen, L. & Li, H. Bcl-XL: a multifunctional anti-apoptotic protein. Pharm. Res. 151, 104547 (2020). · DOI · Paper page
- Ngoi, N. Y. L. et al. Targeting mitochondrial apoptosis to overcome treatment resistance in cancer. Cancers 12, https://doi.org/10.3390/cancers12030574 (2020). · DOI
- Lessene, G., Czabotar, P. E. & Colman, P. M. BCL-2 family antagonists for cancer therapy. Nat. Rev. Drug Disco. 7, 989–1000 (2008). · DOI · Paper page
- Petros, A. M., Gunasekera, A., Xu, N., Olejniczak, E. T. & Fesik, S. W. Defining the p53 DNA-binding domain/Bcl-x(L)-binding interface using NMR. FEBS Lett. 559, 171–174 (2004). · DOI · Paper page
- Follis, A. V. et al. The DNA-binding domain mediates both nuclear and cytosolic functions of p53. Nat. Struct. Mol. Biol. 21, 535–543 (2014). · DOI · Paper page
- Sot, B., Freund, S. M. & Fersht, A. R. Comparative biophysical characterization of p53 with the pro-apoptotic BAK and the anti-apoptotic BCL-xL. J. Biol. Chem. 282, 29193–29200 (2007). · DOI · Paper page
- Hagn, F. et al. BclxL changes conformation upon binding to wild-type but not mutant p53 DNA binding domain. J. Biol. Chem. 285, 3439–3450 (2010). · DOI · Paper page
- Tomita, Y. et al. WT p53, but not tumor-derived mutants, bind to Bcl2 via the DNA binding domain and induce mitochondrial permeabilization. J. Biol. Chem. 281, 8600–8606 (2006). · DOI · Paper page
- Lee, E. F. et al. Crystal structure of ABT-737 complexed with Bcl-xL: implications for selectivity of antagonists of the Bcl-2 family. Cell Death Differ. 14, 1711–1713 (2007). · DOI · Paper page
- Muchmore, S. W. et al. X-ray and NMR structure of human Bcl-xL, an inhibitor of programmed cell death. Nature 381, 335–341 (1996). · DOI · Paper page
- Reddy Chichili, V. P., Kumar, V. & Sivaraman, J. Linkers in the structural biology of protein-protein interactions. Protein Sci. 22, 153–167 (2013). · DOI · Paper page
- Friedman, P. N., Chen, X., Bargonetti, J. & Prives, C. The p53 protein is an unusually shaped tetramer that binds directly to DNA. Proc. Natl Acad. Sci. USA 90, 3319–3323 (1993). · DOI · Paper page
- Wang, Y., Rosengarth, A. & Luecke, H. Structure of the human p53 core domain in the absence of DNA. Acta Crystallogr D. Biol. Crystallogr 63, 276–281 (2007). · DOI · Paper page
- Tidow, H. et al. Quaternary structures of tumor suppressor p53 and a specific p53 DNA complex. Proc. Natl Acad. Sci. USA 104, 12324–12329 (2007). · DOI · Paper page
- Lee, E. F. & Fairlie, W. D. The structural biology of Bcl-xL. Int. J. Mol. Sci. 20, https://doi.org/10.3390/ijms20092234 (2019). · DOI · Paper page
- Rajan, S., Choi, M., Baek, K. & Yoon, H. S. Bh3 induced conformational changes in Bcl-Xl revealed by crystal structure and comparative analysis. Proteins 83, 1262–1272 (2015). · DOI · Paper page
- O’Neill, J. W., Manion, M. K., Maguire, B. & Hockenbery, D. M. BCL-XL dimerization by three-dimensional domain swapping. J. Mol. Biol. 356, 367–381 (2006). · DOI
- Rajan, S. et al. Structural transition in Bcl-xL and its potential association with mitochondrial calcium ion transport. Sci. Rep. 5, 10609 (2015). · DOI
- Ku, B., Liang, C., Jung, J. U. & Oh, B. H. Evidence that inhibition of BAX activation by BCL-2 involves its tight and preferential interaction with the BH3 domain of BAX. Cell Res. 21, 627–641 (2011). · DOI · Paper page
- Burke, P. J. Mitochondria, bioenergetics and apoptosis in cancer. Trends Cancer 3, 857–870 (2017). · DOI · Paper page
- Mohammad, R. M. et al. Broad targeting of resistance to apoptosis in cancer. Semin Cancer Biol. 35(Suppl), S78–S103 (2015). · DOI · Paper page
- Martinez-Zapien, D. et al. Structure of the E6/E6AP/p53 complex required for HPV-mediated degradation of p53. Nature 529, 541–545 (2016). · DOI · Paper page
- Lilyestrom, W., Klein, M. G., Zhang, R., Joachimiak, A. & Chen, X. S. Crystal structure of SV40 large T-antigen bound to p53: interplay between a viral oncoprotein and a cellular tumor suppressor. Genes Dev. 20, 2373–2382 (2006). · DOI · Paper page
- Joo, W. S. et al. Structure of the 53BP1 BRCT region bound to p53 and its comparison to the Brca1 BRCT structure. Genes Dev. 16, 583–593 (2002). · DOI · Paper page
- Gorina, S. & Pavletich, N. P. Structure of the p53 tumor suppressor bound to the ankyrin and SH3 domains of 53BP2. Science 274, 1001–1005 (1996). · DOI · Paper page
- Chen, X. et al. Structural basis for DNA recognition by FOXC2. Nucleic Acids Res. 47, 3752–3764 (2019). · DOI
- Wang, Q.-S. et al. Upgrade of macromolecular crystallography beamline BL17U1 at SSRF. Nucl. Sci. Tech. 29, 68 (2018). · DOI · Paper page
- Zhang, W.-Z. et al. The protein complex crystallography beamline (BL19U1) at the Shanghai synchrotron radiation facility. Nucl. Sci. Tech. 30, 170 (2019). · DOI · Paper page
- Otwinowski, Z. & Minor, W. in Methods in Enzymology Vol. 276 307–326 (Academic Press, 1997). · DOI · Paper page
- Adams, P. D. et al. The Phenix software for automated determination of macromolecular structures. Methods 55, 94–106 (2011). · DOI · Paper page
- Emsley, P. & Cowtan, K. Coot: model-building tools for molecular graphics. Acta Crystallogr D. Biol. Crystallogr 60, 2126–2132 (2004). · DOI · Paper page
Cited by
Targeting p53 pathways: mechanisms, structures, and advances in therapy
Wang, H., Guo, M., Wei, H., & Chen, Y. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01347-1 · Cited by 1,016
“p53 binds physically to anti-apoptotic proteins (Bcl-2, Bcl-xL and Mcl-1), thereby indirectly inducing apoptosis.(71) p53 directly activates the pro-apoptotic protein Bak or disrupts the Mcl-1 and Bak complex, releasing Bak and initiating apoptosis.”
BackgroundSelf-citationp53: from understanding its structure to advances in therapeutic targeting
Wang, W., Liu, X., Liu, H., Abolhassani, H., Yan, H., Zhang, H., & Wang, X. (2026) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-025-02549-5 · Cited by 30
Metadata
- Authors
- Wei, H., Qu, L., Dai, S., Li, Y., Wang, H., Feng, Y., Chen, X., Jiang, L., Guo, M., Li, J., Chen, Z., Chen, L., Zhang, Y., & Chen, Y.
- Venue
- Nature Communications
- Published
- 2021-04-16
- Volume
- 12
- Issue
- 1
- ISSN
- 2041-1723
- Cited by
- 114
- References
- 9
- Language
- en
- Licence
- creativecommons.org/licenses/by/4.0 (tdm)
- creativecommons.org/licenses/by/4.0 (vor)
- Funders
- National Natural Science Foundation of China (81974074, 81570537, 31900880, 81902858)
- Science and Technology Planning Project of Hunan Province
- China Postdoctoral Science Foundation (2019M652805)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Structural insight into the molecular mechanism of p53-mediated mitochondrial apoptosis. https://app.cochat.ai/papers/10.1038/s41467-021-22655-6
- The paper
- Wei, H., Qu, L., Dai, S., Li, Y., Wang, H., Feng, Y., Chen, X., Jiang, L., Guo, M., Li, J., Chen, Z., Chen, L., Zhang, Y., & Chen, Y. (2021). Structural insight into the molecular mechanism of p53-mediated mitochondrial apoptosis. Nature Communications. https://doi.org/10.1038/s41467-021-22655-6
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.